Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.

Torres RA, Barr M, Thorn M, Gregory G, Kiely S, Chanin E, Carlo C, Martin M, Thornton J.

Am J Med. 1993 Dec;95(6):573-83.

PMID:
8018144
2.

Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients.

Opravil M, Hirschel B, Lazzarin A, Heald A, Pechère M, Rüttimann S, Iten A, von Overbeck J, Oertle D, Praz G, et al.

Clin Infect Dis. 1995 Mar;20(3):531-41.

PMID:
7756472
3.

Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.

Girard PM, Landman R, Gaudebout C, Olivares R, Saimot AG, Jelazko P, Gaudebout C, Certain A, Boué F, Bouvet E, et al.

N Engl J Med. 1993 May 27;328(21):1514-20.

4.

Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.

Mallolas J, Zamora L, Gatell JM, Miró JM, Vernet E, Valls ME, Soriano E, SanMiguel JG.

AIDS. 1993 Jan;7(1):59-64.

PMID:
8442918
5.

Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.

Antinori A, Murri R, Ammassari A, De Luca A, Linzalone A, Cingolani A, Damiano F, Maiuro G, Vecchiet J, Scoppettuolo G.

AIDS. 1995 Dec;9(12):1343-50.

PMID:
8605054
6.
7.

Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Study Group.

Salmon-Ceron D, Fontbonne A, Saba J, May T, Raffi F, Chidiac C, Patey O, Aboulker JP, Schwartz D, Vildé JL.

J Infect Dis. 1995 Sep;172(3):656-64. Erratum in: J Infect Dis 1996 Jan;173(1):277.

PMID:
7658056
9.
11.
12.

Aerosolized pentamidine as primary prophylaxis for Pneumocystis carinii pneumonia: efficacy, mortality and morbidity.

Lidman C, Berglund O, Tynell E, Lindbäck S, Elvin K.

AIDS. 1994 Jul;8(7):935-9.

PMID:
7946102
13.

A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.

Bozzette SA, Finkelstein DM, Spector SA, Frame P, Powderly WG, He W, Phillips L, Craven D, van der Horst C, Feinberg J.

N Engl J Med. 1995 Mar 16;332(11):693-9.

14.
15.

Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.

Bucher HC, Griffith L, Guyatt GH, Opravil M.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 1;15(2):104-14.

PMID:
9241108
16.

Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.

Saah AJ, Hoover DR, Peng Y, Phair JP, Visscher B, Kingsley LA, Schrager LK.

JAMA. 1995 Apr 19;273(15):1197-202.

PMID:
7707627
17.

Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS.

Carr A, Tindall B, Brew BJ, Marriott DJ, Harkness JL, Penny R, Cooper DA.

Ann Intern Med. 1992 Jul 15;117(2):106-11.

PMID:
1351371
18.

A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.

Schneider MM, Hoepelman AI, Eeftinck Schattenkerk JK, Nielsen TL, van der Graaf Y, Frissen JP, van der Ende IM, Kolsters AF, Borleffs JC.

N Engl J Med. 1992 Dec 24;327(26):1836-41.

20.

A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.

Ioannidis JP, Cappelleri JC, Skolnik PR, Lau J, Sacks HS.

Arch Intern Med. 1996 Jan 22;156(2):177-88.

PMID:
8546551

Supplemental Content

Support Center